PARSIPPANY, N.J. (AP) — Watson Pharmaceuticals Inc. said Friday it filed an application with the Food and Drug Administration to market a generic version of the birth control pill Loestrin FE, made by Warner Chilcott.
Warner Chilcott filed a lawsuit in New Jersey district court Wednesday to block Watson from launching the drug. Branded drugmakers routinely file lawsuits against generic drugmakers to delay the launch of cheaper versions of their drugs.
Loestrin had sales of $86 million for the 12 months ended March 31, according to health caredata firm IMS Health.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
